宫颈病变合并人乳头瘤病毒感染患者肿瘤标志物等影响因素分析
山东第二医科大学附属医院
目的 分析肿瘤标志物、辅助性T细胞1型(Th1)细胞因子、辅助性T细胞2型(Th2)细胞因子在宫颈病变合并人乳头瘤病毒(HPV)感染中的变化及影响因素。方法 选定山东第二医科大学附属医院2022年6月至2023年12月收入的150例宫颈病变患者,根据感染HPV情况分为高危组(n=79)、低危组(n=32)、混合组(n=21)、未合并组(n=18)。对比四组患者肿瘤标志物、Th1细胞因子与Th2细胞因子,采用Logistic回归分析宫颈病变合并HPV的影响因素。结果 高危组和混合组鳞状上皮细胞癌抗原(SCCA)、癌胚抗原(CEA)、糖类抗原125(CA125)、白细胞介素-4(IL-4)高于低危组、未合并组(P<0.05),高危组、混合组IL-12、IFN-γ低于低危组和未合并组(P<0.05)。四组CA199、IL-6经统计学对比,差异无统计学意义(P>0.05)。Logistic回归分析显示,流产次数[OR(95%CI):9.826(1.003~10.286)]、SCCA[OR(95%CI):4.029(1.247~19.805)]、CA125[OR(95%CI):3.846(1.049~1.848)]、IL-12[OR(95%CI):8.849(3.549~9.870)]为宫颈病变合并HPV感染的影响因素(P<0.05)。结论 宫颈病变合并HPV感染患者SCCA、CEA、CA125、IL-4高,IL-12、IFN-γ低,危险因素是流产次数多、IL-12低、SCCA、CA125高,临床应根据以上危险因素,及早给予针对性干预,最大限度降低HPV感染率。
Objective To analyze the changes and influencing factors of tumor markers, T helper 1(Th1) cytokines and T helper 2(Th2) cytokines in patients with cervical lesionss complicated with human papillomavirus(HPV) infection. Methods A total of 150 patients with cervical lesionss admitted to the Affiliated Hospital of Shandong Second Medical University from June 2022 to December 2023 were selected and divided into highrisk group(n=79), low-risk group(n=32), mixed group(n=21), and non-combined group(n=18) according to the HPV infection status. Tumor markers and Th1 cytokines and Th2 cytokines were compared among the four groups. Logistic regression was used to analyze the influencing factors of cervical lesionss combined with HPV. Results The levels of SCCA, CEA, CA125 and IL-4 in the high-risk group and the mixed group were higher than those in the low-risk group and the non-combined group(P<0.05), while the levels of IL-12 and IFN-γ in the high-risk group and the mixed group were lower than those in the low-risk group and the non-combined group(P<0.05). The four groups of CA199 and IL-6 were statistically compared, and there was no difference(P>0.05). Logistic regression analysis revealed that the number of miscarriages [OR(95% CI): 9.826(1.003~10.286)], SCCA [OR(95% CI): 4.029(1.247~19.805)], CA125 [OR(95% CI): 3.846(1.049~1.848)], and IL12 [OR(95% CI): 0.986(3.549~9.870)] were the influencing factors for cervical lesionss combined with HPV infection(P<0.05). Conclusion Patients with cervical lesionss combined with HPV infection have high levels of SCCA, CEA, CA125, and IL-4, while low levels of IL-12 and IFN-γ. The risk factors are frequent miscarriages, low IL-12, and high levels of SCCA and CA125. Clinically, targeted intervention should be given as early as possible based on the above risk factors to minimize the HPV infection rate to the greatest extent.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 12 条- [1]陈秀英,陈娜,李晓丹,等.血清Th1/Th2细胞因子联合肿瘤标志物诊断HR-HPV阳性宫颈癌的价值分析[J].检验医学与临床,2025,22(9):1226-1230.
- [2]丛蓉,翟青枝.阴道微生态与人乳头瘤病毒感染及宫颈病变的相关性[J].国际妇产科学杂志,2023,50(3):286-289.
- [3]连晓红,仝亚娟,李丽丽.癌胚抗原、糖类抗原19-9和人乳头瘤病毒联合检测对宫颈癌的诊断价值[J].癌症进展,2023,21(6):660-662.
- [4]王忆群,马霞,李晓丹.女性生殖道高危HPV感染患者阴道菌群微生态和免疫功能Th1/Th2失衡的相关性分析[J].中国妇幼保健,2024,39(4):670-673.
- [5]张倡宁,刘潇阳,李青,等.不同检测标志物在宫颈腺癌中的诊断和预后预测价值评估[J].中华肿瘤杂志,2023,45(5):402-409.
- [6]雷田雨,王夫浩,李晓慧,等.SLC7A11对HPV阳性宫颈癌患者免疫应答和生存的影响[J].临床与病理杂志,2023,43(7):1323-1332.
- [7]温静,朱慧娟,张爽.HR-HPV感染CIN患者阴道微生态与肿瘤标志物的相关性及联合检测价值[J].安徽医学,2024,45(12):1491-1496.
- [8]张艳敏,王海颖,李登州,等.血清Th1/Th2、Hmga1、PKM2表达水平及其联合HPV诊断宫颈癌的价值[J].海南医学,2024,35(9):1293-1298.
- [9]丁洁,文丽芳,王全义,等.HR-HPV宫颈癌患者外周血Th1/Th2细胞因子变化及其意义[J].中国艾滋病性病,2023,29(4):443-447.
- [10]伊力努尔·哈力甫,马云霞,梁俊琴,等.尖锐湿疣患者人乳头瘤病毒基因型分布及Th1/Th2亚群失衡与复发的关系[J].中国性科学,2023,32(9):144-148.
- [11]秦丽欣,李枫,白娅琴,等.宫颈癌患者高危型人乳头瘤病毒感染状况及其与阴道微环境、氧化应激水平及Th1/Th2细胞因子的关系研究[J].现代生物医学进展,2023,23(4):787-791.
- [12]罗春艳,刘洁,刘丽珍,等.宫颈病变患者感染高危型HPV分型及其影响因素与模型构建[J].中华医院感染学杂志,2023,33(23):3630-3634.
| 文章编号 | 2026-04-035(期号内编号) |
|---|---|
| 栏目 | 检验与方法 |
| 作者 | 尹笑倩;潘姿璇 |
| 作者单位 | 山东第二医科大学附属医院 |
| 中图分类号 | R737.33 |
| 卷期页码 | 2026, 2(04): 137-140 |
| 发布时间 | 2026-07-15 |
| 出版时间 | 2026-07-15 |
| 引用信息 | [1]尹笑倩,潘姿璇.宫颈病变合并人乳头瘤病毒感染患者肿瘤标志物等影响因素分析[J].疾病预防与控制,2026,2(04):137-140. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-09-22T12:15:40 |